Insight Genetics is committed to working with the pharmaceutical industry to further develop existing and novel treatment options for the TNBC community.
In addition to being a stand-alone clinical diagnostic assay for TNBC patients, Insight TNBCtype™ can be a platform for biomarker discovery.
Identification of TNBC biomarkers provides a strong foundation for successful targeted drug development and approval.
A number of drug classes stand to benefit from the additional clarity offered by the molecular profiling information provided by the Insight TNBCtype platform.
Please contact us if Insight TNBCtype can help enroll patients for your clinical trial.